1.. INTRODUCTION
================

Colorectal cancer is the third most common cancer in male and female population, just behind prostate cancer, breast cancer and lung cancer leading in both genders. In 2018, over 1.8 million new cases were diagnosed. Western countries are observing a growing incidence of colon cancer due to increased consumption of meat and animal originated fat. Surgical treatment of colorectal cancer is based on tumor resection and removal of surrounding lymph nodes. Operative principles of any resection, whether minimally invasive technique (laparoscopic) or an open surgical approach, need to follow oncological guidelines of resection.

2.. AIM
=======

The goal of the study is to present data of five year retrospective research of surgical treatment of colorectal cancer at the Clinic for General and Abdominal surgery, Clinical Centre University of Sarajevo.

3.. METHODS
===========

The study represents a five year long clinical research (2014-2018) on patients surgically treated for colorectal cancer on the Clinic for General and Abdominal Surgery, University of Sarajevo ( Ethical committee license number 10-01-2-1186/19, Sarajevo, July 12^th^ 2019, 10-01-35568 University of Sarajevo, Medical faculty). Material used in study is patient's histories, operative protocols and hospitalized patient protocols. All data were analyzed by descriptive statistics and presented in tables and graphs.

4.. RESULTS
===========

In the period 2014-2018, total number of n=11 172 patients were hospitalized at the Clinic, of which n=732 were operatively treated for colon tumor (cancer). Out of total number of patients 69, 80% were treated in elective program and those patients had pathologically verified malignant disease which was presented on a multi-disciplinary oncologic meeting, while 30, 20% were treated as emergency cases who were postoperatively confirmed as malignant.

Gender representation of operated patients was almost equal, 51, 09% were male patients, 48, 36% were females.

According to age groups, colorectal cancer is the most frequent in persons over the age of 50 (93%). Patients in the age group 20-49 years account for 6, 83%, with an increase of colorectal cancer worldwide in this age group. Youngest surgically treated patient was 25 years old, while the oldest was 94.

Majority of patients are from the Sarajevo Canton, followed by Zenica-Doboj Canton 3, 65%, and Bosnia-Podrinje canton 2, 05%.

Speaking of surgical treatment of colorectal cancer majority of operations 97, 20% was performed by using an open method, while only n=16 of operation started laparoscopically, out of which n=12 or 2, 10% were successfully finished using minimally invasive procedure, whereas in four a conversion was performed. With regards to consulted literature, it is impossible to make comparison between open and minimally invasive procedures and to bring conclusions on such small pattern.

Out of total n=732 operated patients, in n=96 patients or 3, 11%, a re-intervention was performed, with postoperative intestinal entanglement and wound dehiscence as a most common reason for re-intervention. Average hospitalization by patient was 15, 9 days.

In the five year review we noted n=30 (4, 10%) of fatal postoperative outcomes.

Most common localization of primary tumor was in rectum, and most commonly histological type of tumor was adenocarcinoma (79%).

5.. DISCUSSION
==============

Out of total number of hospitalized patients in the five year period, both elective and emergency cases of colorectal cancer accounted for 6, 55%. Difference between genders was only 2% in favor of male population. Consulted literature shows similar results in favor of male population, stating that male population faces also higher morbidity and mortality rates in comparison to female in all age groups.

Over 90% of patients are those resident in the Sarajevo Canton. The remaining part are patients from other cantons, Republic Srpska entity (0, 27%) and foreign citizens (0, 41%).

Only 2, 80% of operative procedures on colorectal cancer started by using minimally invasive technique (laparoscopy). Over 97% of operations were performed by using open method. Global trends, as well as current literature, favor laparoscopic (minimally invasive) technique. Numerous researches highlight benefits of laparoscopy, such as reduced blood loss intraoperatively, better and faster postoperative recovery, better immune ad inflammatory response compared to open method. Time of overall survival (OS) and Progression free period (PFS) has no importance in relation to selected operation treatment (LAP vs open).

The only lack of laparoscopic technique compared to open technique was the financial aspect (operational costs are higher in laparoscopy) as well as duration of surgery which is somewhat longer. Duration of hospitalization upon open method procedures is twice as longer. Literature shows significantly shorter period of hospitalization in patients treated laparoscopically (approx. 7 days). Three year research of postoperative mortality (POM) 30 days upon colorectal resection is 5%. In our research postoperative mortality is noted only in time of hospitalization, so it is to assume that it is somewhat higher, in accordance to literature. The most common localization of malignant tumor is left colon (descendent, sigmoid, rectum) with more than 75% of cases, the rest consists of right colon, transversal colon and anal canal. Literature shows most frequent localization of tumor in the right colon area. Adenocarcinoma is the most common patho-histological type of tumors in almost 80% of patients in examined group. Consulted literature also shows that mucinous adenocarcinoma is represented in 10-20% which correlates with our research. Nowadays, the most cited classification is the one referring to low grade and high grade tumors, low grade tumors (G1 and G2) representing 78%, while high grade (G3 and G4) in 20%. In our research, data correspond to current scientific indicators, however grade tumor was represented in significantly lower number of cases than showed in current literature (15-20%). According to the Dukes classification, most common type is C stage of cancer with a total of 59, 16% of cases, with five year survival rate of 50%. The best chance for five year survival is in A group, over 90%.

6.. CONCLUSION
==============

A better prevention and early detection are required in order to reduce rate of newly diagnosed cases which leads to more efficient treating and longer survival of patients suffering from colon cancer.

Operative surgical principles need to be adjusted to modern trends, that is, to minimally invasive procedures (laparoscopic procedures, robotic surgery).

Digitalization of medical records for the purpose of easier patient follow-up and more efficient scientific projects is also very important.
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###### Localization of tumor

  ----- ------------------ ----- --------
  1\.   Anus               11    1,59%
  2\.   Ascending colon    174   25,11%
  3\.   Descending colon   35    5,05%
  4\.   Rectum             320   46,18%
  5\.   Sigmoid colon      123   17,75%
  6\.   Transverse colon   30    4,33%
  ----- ------------------ ----- --------

###### Histological diagnoses

  ------ ------------------------------------ ----- --------
  1\.    Adenocarcinoma                       365   79,00%
  2\.    Mucinous colorectal adenocarcinoma   67    14,50%
  3\.    Adenocarcinoma recidivans            5     1,08%
  4\.    Carcinoma in situ                    2     0,43%
  5\.    Carcinoma lobululare meta colonis    1     0,22%
  6\.    Neuroendocrine carcinoma             2     0,43%
  7\.    Leiomyosarcoma                       1     0,22%
  8\.    Melanoma malignum recti              1     0,22%
  9\.    Pseudomyxoma peritonei               1     0,22%
  10\.   Signet ring cell carcinoma           5     1,08%
  11\.   Squamous cell carcinoma              4     0,87%
  12\.   Serrated adenoma                     6     1,30%
  13\.   Tubulovillous adenoma                2     0,43%
  ------ ------------------------------------ ----- --------

###### Tumor grade

  ------------ ----- --------
  CIS          6     1,41%
  Gradus I     20    4,69%
  Gradus II    316   74,18%
  Gradus III   82    19,25%
  Gradus IV    2     0,47%
  ------------ ----- --------

###### Tumor staging. The Dukes classification

  --------- ----- --------
  Dukes A   25    9,54%
  Dukes B   82    31,30%
  Dukes C   155   59,16%
  --------- ----- --------
